Searching for new targets to use in liquid biopsy, a multimodal diagnostic tool in clinical oncology (TBD)

Liquid biopsy consists of the detection and isolation of circulating tumor cells, circulating tumor DNA and exosomes, as a source of genomic and proteomic information in patients with cancer.It is a revolutionary technique that is opening previously unexpected perspectives. Newly developed techniques and next-generation sequencing analyses allow a broad application of liquid biopsy in a wide range of settings. Initially correlated to prognosis, liquid biopsy data are now being studied for cancer diagnosis, including screenings, and most importantly for the prediction of response or resistance to given treatments. Still application is far from daily use in clinical application but ongoing research is leading the way to a new era in oncology.

Teacher

S. Garavaglia

Topic

biochemistry

Date

TBD

Exam

No